X-Mozilla-Status: 0000
X-Mozilla-Status2: 00000000
X-PQ-Received: mpq207.prodcr.mail.ne1.yahoo.com; Wed Jul 25 18:44:35 UTC 2018
X-Apparently-To: jeeproject@yahoo.com; Wed, 25 Jul 2018 18:44:35 +0000
Return-Path: <bounce-31110487_HTML-1027729945-54390757-10732224-401@bounce.mail.23andme.com>
Received-SPF: pass (domain of bounce.mail.23andme.com designates 136.147.187.132 as permitted sender)
X-YMailISG: EGGanugWLDvRFN8i8zAI_DiK2NY4h3PBqn30SJsbUso7OtQs
 Xr9AphzX9F9ySNkyZcY8zV8sBtjYkZi92eNcCjBPHf8glDK5zBCiSC3ZWkpt
 EdZTOA3uIwUJMdZtT7arRVJgupbLbsqFOsh2wLtANaLr32RCQnWb.RHIt6jI
 LvfArv7TKFecBs1TUhEYP72JLFBh47gXi.foWng3qYxy09iKktujTtX5Oi7o
 Hc0IwmA9UhD5zyRDHJflo6UsHw6N.otRmvRWuJVsVeorvcdyRj2OfWa3ed4a
 qH53352QpEp7jF3mfSSGZoGGJF9h0.5SM5Pn4634R44AN1TIcW4hInNnP.Kt
 EnA7A9MsdR8YIcTqnIUUSlGjOe89ga3XJWPBrjSP_aRELPmUdCt9dT38o_z0
 kjPbHeGWH8eNVEqE4G1XjFfRnyMSKNNbevy6AOzTRHKqpSoUUZ3eUUEfKpYm
 hqUjh9W9bSwuT_udeA6XKRAfQv.UqbeRy2byjjUUm.P2aIQpPi_5GDrmHbM2
 RhMMYBaPQOERrUduxkZQ9O.ThJJswhC_ErrVIOsN7yxIAfxx.xTjEzkpMCYE
 NAj5592GIJpoIjvofHeFZtHfbSAH.vDFhmEknZZR8x5OUMFAFT_o7bDfdwwp
 NE.u8OnwoxtHWjbrx5uWTj6cMjTGbiAMHHItKPr8eyTQADrUuS6ElCBhpSEs
 y4XCgAZ.aqOGkp8T1Qpy8GoKuWBEtPT2cHfkmtJhdFEeOQ7B.AgnPHGEaopv
 KJjw2k.fC5SbmabHu5dnWQHuAMC0ZVwvQy2ujLUGmk9quTv7vkX2eLsU1apk
 .ij3VgJOTOL5x2HYMWi88JycGf6k9S4GM.heDTdQDOLFiyvdc_qog8lIeXLl
 qqxWyVFOzjjKPxwkdEsX5R4lbVCFcWABiLOBcTAL.SDOS7Iqf1.9SAnaZoG_
 94ZnhZgJceCy6R6uC21Whgv8ZO_.Z_FDYjnB3SGPbg4lXDoF_ioXM0USgd0d
 H5O6Sc6FzHjgMUdof82cwYqK7Ot2LKYYCIfXev5QWqBXvW_9b4UilAP.T1ns
 gitVf0sppvty8hZjmarwNyT._RzUwiYJS8as83sQrvTmtIxXk_5Ufr3KyTnS
 IoDxo4tw_my7EcpHXoFl1BQhqgh1vRDqX6G9p4Nh_2bZEhuI_C4mfb7Y.FyY
 CkB14e8kHvjwE6hZgwuE3fU1cu6.PiNOyAbNp5921v8QB5jHms37qQqrPz.E
 tzhgHV.oYZhE0tgJa4Zs7gkTtl2LJjnEXbN.4hD8C9uKl0uceudf6RM1H9MV
 6w--
X-Originating-IP: [136.147.187.132]
Authentication-Results: mta4079.mail.ne1.yahoo.com  from=mail.23andme.com; domainkeys=pass (ok);  from=mail.23andme.com; dkim=pass (ok)
Received: from 127.0.0.1  (EHLO mta.mail.23andme.com) (136.147.187.132)
  by mta4079.mail.ne1.yahoo.com with SMTPS; Wed, 25 Jul 2018 18:44:34 +0000
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=200608; d=mail.23andme.com;
 h=From:To:Subject:Date:List-Unsubscribe:MIME-Version:List-ID:Message-ID:Content-Type; i=noreply@mail.23andme.com;
 bh=oPhVwI0akOJoJ/AioyS+DLY0/Lg=;
 b=quseqrmzhEuxu5lHz9LUcL+H08ty5N1pFSO/XEkr/m0GyJq6pXnwywtcvg/4Nqs24Qwv+pmprCGW
   83jX35UQspfCcS76q8yWR6WccVK34npUJQ2RYRmozZA4fqYiWGFW5mEkytVuIekT0edAoD7vdCy/
   d0RDyMFX/DcNwXQvdhA=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=200608; d=mail.23andme.com;
 b=YNNnGHfT7ADXgRV0qrZ4S0D12Otu0H/wBsabPY+VKxSjoBEn7qw0fT3ATia/I+oStYZyuDnm5Aiq
   jcfM6+rI91us1ellY/5qpx4nYCTitEYEd4WgqNSOSWldGFfaAe/sPqdO3uaGbWrI+2Xcdb9hBnXv
   2joZtYeRz3Q39sSDne0=;
Received: by mta.mail.23andme.com id hb32h4163hs7 for <jeeproject@yahoo.com>; Wed, 25 Jul 2018 18:44:29 +0000 (envelope-from <bounce-31110487_HTML-1027729945-54390757-10732224-401@bounce.mail.23andme.com>)
From: "23andMe" <noreply@mail.23andme.com>
To: <jeeproject@yahoo.com>
Subject: A note from Anne Wojcicki, CEO
Date: Wed, 25 Jul 2018 12:44:29 -0600
List-Unsubscribe: <mailto:leave-fc521771746504797d131f2d205921-fdf115707763037f7c1d7470-fe571174766d047a7013-fe6a15707267067f7710-ff6a107074@leave.mail.23andme.com>
MIME-Version: 1.0
List-ID: <10732224.xt.local>
X-CSA-Complaints: whitelistcomplaints@eco.de
x-job: 10732224_54390757
Message-ID: <c6aba3cf-6966-4cfa-8319-2d689d2f6681@ind1s01mta514.xt.local>
Content-Type: multipart/alternative;
	boundary="lGRnLKTb8Md2=_?:"
Content-Length: 14179

This is a multi-part message in MIME format.

--lGRnLKTb8Md2=_?:
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit


https://click.mail.23andme.com/?qs=f853fc4808ead70686fd4dd573c2d8fb53d37490831fef4571d7c3d77e311c2b6738b05943a0fb96767230429fa9d2cb9fed65c9953d1834 


Dear Sam,


 Since the inception of 23andMe, our mission has been to help people access, understand and benefit from the human genome. We have spent the last decade focused on enabling people to get access to their genome and understand what it means. We have also built a significant research team that has published over 100 scientific papers. In 2015, we launched 23andMe Therapeutics to develop novel treatments and cures based on genetic insights from the consented 23andMe community.




Today, I am thrilled to announce that we are launching a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make those novel treatments and cures a reality.



I hear regularly from customers, like you, that they want to be part of a solution that is improving health care. We all have some disease or health issue that we care about. 23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen. By working with GSK, we believe we will accelerate the development of breakthroughs. Our genetic research - powered by millions of customers who have agreed to contribute - combined with GSK's expertise in drug discovery and development, gives us the best chance for success.




Our top priority is you, the customer, and empowering you with the options to participate in research. As always, you choose whether or not to participate in research. You can choose to
https://click.mail.23andme.com/?qs=f853fc4808ead706b011a3dd820813a75572dbbbb2485833279ec547c4dffcedfc68b79f9b53b00d744c35c8691e3329f2b3608cf9941280 
opt-in or opt-out  at any time.



I started 23andMe with the belief that by getting people interested in learning about themselves and participating in research, we would all benefit. Today is an important milestone in how 23andMe will be able to impact the lives of those with disease and how we will be able to improve the future of healthcare.



Anne 


 You are receiving this email because you are a customer of 23andMe.(c) 2007&#45;2018 23andMe, Inc.23andMe, Inc., 899 W. Evelyn Avenue, Mountain View, CA 94041, USA
https://click.mail.23andme.com/?qs=f853fc4808ead70634ef70bc168a134007724080addf67f4adf5ad838b5aed054c4c583637e9537777565c349f3b74f9fad3272a488430c5 
update your 23andMe email preferences  |  

https://click.mail.23andme.com/unsub_center.aspx?qs=1890449f0bb25765a87d3bc0564352041d9b58c0c42e947cf9acf90f4a43cd74a6e8ace2d0d7e6ba4958bdc889d5f1bffc7c12ba13ab13dd82f2ba7a94c33dd179743a5537076b41a676079ec74f26bf 
unsubscribe from 23andMe emails 





--lGRnLKTb8Md2=_?:
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

<!DOCTYPE html>
<html>
<head>
<title></title>
<!-- Template: bdy_btn.html -->
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<style type="text/css">
    /* CLIENT-SPECIFIC STYLES */
    body, table, td, a{-webkit-text-size-adjust: 100%; -ms-text-size-adjust: 100%; -webkit-font-smoothing: antialiased !important;} /* Prevent WebKit and Windows mobile changing default text sizes */
    table, td{mso-table-lspace: 0pt; mso-table-rspace: 0pt;} /* Remove spacing between tables in Outlook 2007 and up */
    img{-ms-interpolation-mode: bicubic;} /* Allow smoother rendering of resized image in Internet Explorer */

    /* RESET STYLES */
    img{border: 0; height: auto; line-height: 100%; outline: none; text-decoration: none;}
    table{border-collapse: collapse !important;}
    body{height: 100% !important; margin: 0 !important; padding: 0 !important; width: 100% !important;}

    /* iOS BLUE LINKS */
    a[x-apple-data-detectors] {
        color: inherit !important;
        text-decoration: none !important;
        font-size: inherit !important;
        font-family: inherit !important;
        font-weight: inherit !important;
        line-height: inherit !important;
    }

    /* MOBILE STYLES */
    @media screen and (max-width: 525px) {

        /* ALLOWS FOR FLUID TABLES */
        .wrapper {
          width: 100% !important;
            max-width: 100% !important;
        }

        /* ADJUSTS LAYOUT OF LOGO IMAGE */
        .logo img {
          margin: 0 auto !important;
        }

        /* USE THESE CLASSES TO HIDE CONTENT ON MOBILE */
        .mobile-hide {
          display: none !important;
        }

        .img-max {
          max-width: 100% !important;
          width: 100% !important;
          height: auto !important;
        }

        /* FULL-WIDTH TABLES */
        .responsive-table {
          width: 100% !important;
        }

        /* UTILITY CLASSES FOR ADJUSTING PADDING ON MOBILE */
        .padding {
          padding: 10px 5% 15px 5% !important;
        }

        .padding-meta {
          padding: 30px 5% 0px 5% !important;
          text-align: center;
        }

        .padding-copy {
             padding: 10px 5% 10px 5% !important;
          text-align: center;
        }

        .no-padding {
          padding: 0 !important;
        }

        .section-padding {
          padding: 5px 15px 5px 15px !important;
        }

        /* ADJUST BUTTONS ON MOBILE */
        .mobile-button-container {
            margin: 0 auto;
            width: 100% !important;
        }

        .mobile-button {
            padding: 15px !important;
            border: 0 !important;
            font-size: 16px !important;
            display: block !important;
        }

    }

    /* ANDROID CENTER FIX */
    div[style*="margin: 16px 0;"] { margin: 0 !important; }
</style>
</head>

<body style="margin: 0 !important; padding: 0 !important; background-color: #f7f9fa;">
<table border="0" cellpadding="0" cellspacing="0" width="100%">
    <tr>
        <td bgcolor="#ffffff" align="center">
            <!--[if (gte mso 9)|(IE)]>
            <table align="center" border="0" cellspacing="0" cellpadding="0" width="560">
            <tr>
            <td align="center" valign="top" width="560">
            <![endif]-->
            <table border="0" cellpadding="0" cellspacing="0" width="100%" style="max-width: 560px;" class="wrapper">
                




                <tr>
                    <td align="center" valign="top" style="padding: 16px 30px 16px 30px;" class="logo">
                        <a href="https://click.mail.23andme.com/?qs=f853fc4808ead70686fd4dd573c2d8fb53d37490831fef4571d7c3d77e311c2b6738b05943a0fb96767230429fa9d2cb9fed65c9953d1834" target="_blank">
                            <img alt="" src="https://permalinks.23andme.com/email/logo_ttam.01.png" width="87" height="60" style="display: block; font-family: 'Avenir Next', Arial, sans-serif; color: #ffffff; font-size: 16px;" border="0">
                        </a>
                    </td>
                </tr>
            </table>
            <!--[if (gte mso 9)|(IE)]>
            </td>
            </tr>
            </table>
            <![endif]-->
        </td>
    </tr>
    <tr>
        <td bgcolor="#ffffff" align="center" style="padding: 0px 0px 40px 0px;" class="section-padding">
            <!--[if (gte mso 9)|(IE)]>
            <table align="center" border="0" cellspacing="0" cellpadding="0" width="560">
            <tr>
            <td align="center" valign="top" width="560">
            <![endif]-->
            <table border="0" cellpadding="0" cellspacing="0" width="100%" style="max-width: 560px;" class="responsive-table">
                <tr>
                    <td>
                        <table width="100%" border="0" cellspacing="0" cellpadding="0">
                            <!-- BODY START -->
                            <tr>
                                <td>
                                    <table width="100%" border="0" cellspacing="0" cellpadding="0">
                                        <tr>
                                            <td align="left" style="padding: 25px 30px 0px 30px; font-size: 16px; line-height: 24px; font-family: 'Avenir Next', Arial, sans-serif; color: #333333;" class="padding">
                                            Dear Sam,<br>
                                            <br>    
                                           Since the inception of 23andMe, our mission has been to help people access, understand and <strong><i>benefit</i></strong> from the human genome. We have spent the last decade focused on enabling people to get access to their genome and understand what it means. We have also built a significant research team that has published over 100 scientific papers. In 2015, we launched 23andMe Therapeutics to develop novel treatments and cures based on genetic insights from the consented 23andMe community.

<br>
                                            <br>    
Today, I am thrilled to announce that we are launching a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make those novel treatments and cures a reality.    
<br>
                                            <br>    
I hear regularly from customers, like you, that they want to be part of a solution that is improving health care. We all have some disease or health issue that we care about. 23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen. By working with GSK, we believe we will accelerate the development of breakthroughs. Our genetic research - powered by millions of customers who have agreed to contribute - combined with GSK's expertise in drug discovery and development, gives us the best chance for success.

<br>
                                            <br>    
Our top priority is you, the customer, and empowering you with the options to participate in research. As always, you choose whether or not to participate in research. You can choose to  <a href="https://click.mail.23andme.com/?qs=f853fc4808ead706b011a3dd820813a75572dbbbb2485833279ec547c4dffcedfc68b79f9b53b00d744c35c8691e3329f2b3608cf9941280">opt-in or opt-out</a> at any time.      
<br>
                                            <br>    
I started 23andMe with the belief that by getting people interested in learning about themselves and participating in research, we would all benefit. Today is an important milestone in how 23andMe will be able to impact the lives of those with disease and how we will be able to improve the future of healthcare.
<br>
                                            <br>    
Anne 
                                            </td>
                                        </tr>
                                    </table>
                                </td>
                            </tr>
                            <!-- BODY END -->
                            <!-- BUTTON START -->
                            <tr>
                                <td align="center">
                                    <table width="100%" border="0" cellspacing="0" cellpadding="0">
                                        <tr>
                                            <td align="center" style="padding-top: 24px; padding-bottom: 24px;" class="padding">
                                                <table border="0" cellspacing="0" cellpadding="0" class="mobile-button-container">
                                                    <tr>
                                                      





                                               </tr>
                                                </table>
                                            </td>
                                        </tr>
                                    </table>
                                </td>
                            </tr>
                            <!-- BUTTON END -->
                        </table>
                    </td>
                </tr>
            </table>
            <!--[if (gte mso 9)|(IE)]>
            </td>
            </tr>
            </table>
            <![endif]-->
        </td>
    </tr>
    <tr style="background-color: #f7f9fa;"><td align="center" style="padding: 0px 0px 0px 0px;" class="section-padding"><!--[if (gte mso 9)|(IE)]><table align="center" border="0" cellspacing="0" cellpadding="0" width="500"><tr><td align="center" valign="top" width="500"><![endif]--><table border="0" cellpadding="0" cellspacing="0" width="100%" style="max-width: 500px;" class="responsive-table"><tr><td align="center" valign="top" style="font-family:'Avenir Next', Arial, sans-serif; font-size:12px; line-height:19px; color:#7e7e7e; padding:38px 0px 38px 0px;"> You are receiving this email because you are a customer of 23andMe.<br/><br/>&copy; 2007&#45;2018 23andMe, Inc.<br/>
<br/>23andMe, Inc., 899 W. Evelyn Avenue, Mountain View, CA 94041, USA<br/><br/><a href="https://click.mail.23andme.com/?qs=f853fc4808ead70634ef70bc168a134007724080addf67f4adf5ad838b5aed054c4c583637e9537777565c349f3b74f9fad3272a488430c5" target="_blank" style="text-decoration:none; color: #7e7e7e;">update your 23andMe email preferences</a><a style="text-decoration:none; color: #7e7e7e;"> | </a><a href="https://click.mail.23andme.com/unsub_center.aspx?qs=1890449f0bb25765a87d3bc0564352041d9b58c0c42e947cf9acf90f4a43cd74a6e8ace2d0d7e6ba4958bdc889d5f1bffc7c12ba13ab13dd82f2ba7a94c33dd179743a5537076b41a676079ec74f26bf" target="_blank"  style="text-decoration:none; color:#7e7e7e;">unsubscribe from 23andMe emails</a></td></tr></table><!--[if (gte mso 9)|(IE)]></td></tr></table><![endif]--></td></tr>
</table>
<img src="https://click.mail.23andme.com/open.aspx?ffcb10-fe571174766d047a7013-fde31d797561007b7112797d-fe6a15707267067f7710-fe661771746504797d13-fdf115707763037f7c1d7470-ff6a107074" width="1" height="1">
</body>
</html>


--lGRnLKTb8Md2=_?:--


